LONDON – Having become popular with both celebrities and investors, diabetes drugs that also promote weight loss, such as Novo Nordisk’s Ozempic, are now being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease.
Diabetes regimens,…
Source: www.japantimes.co.jp – Read more

More Organizations Are Using Software-Based Pentesting
Over 50% of Chief Information Security Officers (CISOs) use software-based penetration testing to enhance their internal testing practices.